CN111419755B - Agilawood fullerene essence and preparation method thereof - Google Patents

Agilawood fullerene essence and preparation method thereof Download PDF

Info

Publication number
CN111419755B
CN111419755B CN202010361692.8A CN202010361692A CN111419755B CN 111419755 B CN111419755 B CN 111419755B CN 202010361692 A CN202010361692 A CN 202010361692A CN 111419755 B CN111419755 B CN 111419755B
Authority
CN
China
Prior art keywords
extract
root extract
agilawood
acid
fullerene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010361692.8A
Other languages
Chinese (zh)
Other versions
CN111419755A (en
Inventor
王美蕾
苏永业
凌瑞儒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanzhi Guangzhou Health Technology Co ltd
Original Assignee
Haikou Nanzhixiang Industry Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haikou Nanzhixiang Industry Co ltd filed Critical Haikou Nanzhixiang Industry Co ltd
Priority to CN202010361692.8A priority Critical patent/CN111419755B/en
Publication of CN111419755A publication Critical patent/CN111419755A/en
Application granted granted Critical
Publication of CN111419755B publication Critical patent/CN111419755B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

The invention provides agilawood fullerene essence and a preparation method thereof, wherein the essence mainly comprises various important amino acids such as butanediol, propylene glycol, fullerene, tyrosine and the like, and components such as agilawood extract, centella asiatica root extract, polygonum cuspidatum root extract, scutellaria baicalensis root extract, tea extract, glycyrrhiza glabra root extract, chamomile flower extract, rosemary leaf extract and the like. The essence disclosed by the invention contains various nutritional and moisturizing components such as various amino acids, fullerene, agilawood extract and the like, can moisturize and moisturize the skin for a long time, tighten the skin, and slow down and improve the generation of wrinkles and fine lines; the skin is brightened, and is tender, smooth and fine, so that the dry and rough skin becomes moist, soft and bright.

Description

Agilawood fullerene essence and preparation method thereof
Technical Field
The invention relates to the technical field of cosmetics, and particularly relates to agilawood fullerene essence and a preparation method thereof.
Background
With the development of social economy and the improvement of the living standard of people, skin-care cosmetics become one of indispensable daily necessities of people. Essence is also called beauty lotion, essence lotion, etc., and is one of facial skin care products. The essence contains various functional components such as plant extracts, ceramide, squalene and the like, and mainly has the effects of moisturizing, whitening, removing freckles, resisting wrinkles and the like. Dry skin generally has poor elasticity and wrinkles deepen, so moisturizing is the basis for smoothing wrinkles and delaying aging. The existing essence products on the market are various in types and various in effects, but the effects of moisturizing and the like of the products are not obvious, and some products even can not achieve the claimed effects of moisturizing, whitening, anti-wrinkle and the like.
Disclosure of Invention
In view of the defects of the prior art, the invention provides agilawood fullerene essence and a preparation method thereof.
The scheme of the invention comprises the following aspects:
the agilawood fullerene essence comprises the following raw materials in percentage by mass:
Figure BDA0002475291760000011
Figure BDA0002475291760000021
wherein the mass ratio of valine, leucine, isoleucine, threonine, methionine, lysine, tryptophan, glycine, alanine, arginine, cystine, proline, serine, tyrosine, aspartic acid, histidine, glycerol, sodium lactate, potassium hydroxide, citric acid, monosodium citrate and pyrrolidone carboxylic acid is (0.3-0.4), (1-2), (0.7-1.0), (0.3-0.5), (2-3), (1-2), (0.5-0.8), (0.6-1), (1-2), (0.3-0.5), (2-3), (1-2), (0.5-0.8), (2-2), (1-2), (0.5-0.8), (0.6-0.6) and (1-0.4).
The mass ratio of the asiatic centella root extract to the giant knotweed rhizome extract to the baical skullcap root extract to the tea leaf extract to the glabrous root extract to the chamomile flower extract to the rosemary leaf extract is 1: (2 to 3), (0.5 to 0.8), (5 to 7), (0.6 to 1), (1 to 2).
The mass ratio of taurine, glutathione, tranexamic acid, potassium methoxysalicylate, hydroxyethyl piperazine ethane sulfonic acid and nonanodiamide MEA is 1 (6-7), (0.5-0.8), (2-3), (1-2) and (2-3).
Preferably, the agilawood fullerene essence comprises the following raw materials in percentage by mass:
Figure BDA0002475291760000031
Figure BDA0002475291760000041
wherein the mass ratio of valine, leucine, isoleucine, threonine, methionine, lysine, tryptophan, glycine, alanine, arginine, cystine, proline, serine, tyrosine, aspartic acid, histidine, glycerol, sodium lactate, potassium hydroxide, citric acid, monosodium citrate and pyrrolidone carboxylic acid is 1:0.4:2:1.0:0.5:3: 2.6: 0.6:0.8:1:2:0.5:3:2:0.8:3: 0.8:1: 0.8:0.6:1: 3;
the mass ratio of the asiatic centella root extract to the giant knotweed rhizome extract to the baical skullcap root extract to the tea leaf extract to the glabrous root extract to the chamomile flower extract to the rosemary leaf extract is 1:3:0.8:0.8:6:0.8: 2;
the mass ratio of taurine, glutathione, tranexamic acid, potassium methoxysalicylate, hydroxyethyl piperazine ethane sulfonic acid and azelaic diamide MEA is 1:7:0.8:2:2: 2.
The invention provides a preparation method of agilawood fullerene essence, which comprises the following steps:
1) dividing the raw materials into a material A, a material B, a material C, a material D and a material F;
a material: butanediol, propylene glycol, hydrolyzed sclerotium rolfsii gum, xanthan gum, sodium hyaluronate, allantoin and trehalose;
b, material B: p-hydroxyacetophenone and 1, 2-hexanediol;
c, material C: propylene glycol, valine, leucine, isoleucine, threonine, methionine, lysine, tryptophan, glycine, alanine, arginine, cystine, proline, serine, tyrosine, aspartic acid, histidine, glycerol, sodium lactate, potassium hydroxide, citric acid, monosodium citrate, pyrrolidone carboxylic acid, nicotinamide, centella asiatica root extract, polygonum cuspidatum root extract, scutellaria baicalensis root extract, tea leaf extract, glycyrrhiza glabra root extract, matricaria chamomilla flower extract, and rosemary leaf extract;
d, material: taurine, glutathione, tranexamic acid, potassium methoxysalicylate, hydroxyethyl piperazine ethanesulfonic acid, azelaic diamide MEA and Chinese eaglewood extract;
f, material: fullerene, beta-glucan, ceramide 1, and hexapeptide-1.
2) Heating water to 85 +/-5 ℃, adding the material A, and stirring and dissolving at 100-200 rpm for 15-20 minutes;
3) cooling the product obtained in the step 2) to 45 +/-2 ℃, sequentially adding the material B, the material C, the material D and the material F, mixing and stirring for 16-20 minutes at 100-200 rpm, filtering, inspecting, filling, packaging, inspecting and warehousing.
The invention further provides another preparation method of the agilawood fullerene essence, which comprises the following steps of:
1) dividing the raw materials into a material A, a material B, a material C, a material D and a material F;
a material: butanediol, propylene glycol, hydrolyzed sclerotium rolfsii gum, xanthan gum, sodium hyaluronate, allantoin and trehalose;
b, material B: p-hydroxyacetophenone and 1, 2-hexanediol;
c, material C: propylene glycol, valine, leucine, isoleucine, threonine, methionine, lysine, tryptophan, glycine, alanine, arginine, cystine, proline, serine, tyrosine, aspartic acid, histidine, glycerol, sodium lactate, potassium hydroxide, citric acid, monosodium citrate, pyrrolidone carboxylic acid, nicotinamide, centella asiatica root extract, polygonum cuspidatum root extract, scutellaria baicalensis root extract, tea leaf extract, glycyrrhiza glabra root extract, matricaria chamomilla flower extract, and rosemary leaf extract;
d, material: taurine, glutathione, tranexamic acid, potassium methoxysalicylate, hydroxyethyl piperazine ethanesulfonic acid, azelaic diamide MEA and Chinese eaglewood extract;
f, material: fullerene, beta-glucan, ceramide 1, and hexapeptide-1.
2) Uniformly mixing the material A, and stirring at 50-75 rpm for 15-20 min at 70 +/-5 ℃;
3) heating water to 85 +/-5 ℃, adding the material C, stirring and dissolving at 100-200 rpm for 15-20 minutes, and adjusting the pH to 7.3-7.8;
4) slowly adding the material obtained in the step 3) into the material obtained in the step 2) at 55 +/-5 ℃, uniformly mixing, carrying out high-pressure homogenization for 3-4 times at the homogenization pressure of 600-800 bar, cooling the material to room temperature, sequentially adding the material B, the material D and the material F, mixing and stirring at 100-200 rpm for 16-20 minutes, filtering, inspecting, filling, packaging, inspecting and warehousing.
Preferably, the pH is 7.6.
Preferably, the homogenization pressure is 600 bar.
Preferably, the mass ratio of the material A to the material C is 1:1.
compared with the prior art, the invention has the beneficial effects that:
the essence disclosed by the invention contains various nutritional and moisturizing components such as amino acids, fullerene, agilawood extract and the like, can moisturize and moisturize skin for a long time, tighten the skin and slow down and improve the generation of wrinkles and fine lines; the skin is brightened, and is tender, smooth and fine, so that the dry and rough skin becomes moist, soft and bright.
The invention also discovers that the photodegradation rate of amino acid components such as tyrosine and tryptophan can be remarkably relieved and the stability of the essence disclosed by the invention is improved by improving the preparation method on the basis of the existing formula.
Detailed Description
In order to better understand the technical content of the invention, specific examples are provided below to further illustrate the invention.
The raw materials used by the facial cleanser are all materials which are commercially available and meet the standards of raw materials of cosmetics.
Figure BDA0002475291760000061
Figure BDA0002475291760000071
Examples 1 to 3
The agilawood fullerene essence is characterized by comprising the following raw materials in percentage by mass:
Figure BDA0002475291760000072
Figure BDA0002475291760000081
wherein the mass ratio of valine, leucine, isoleucine, threonine, methionine, lysine, tryptophan, glycine, alanine, arginine, cystine, proline, serine, tyrosine, aspartic acid, histidine, glycerol, sodium lactate, potassium hydroxide, citric acid, monosodium citrate and pyrrolidone carboxylic acid is 1:0.4:2:1.0:0.5:3: 2.6: 0.6:0.8:1:2:0.5:3:2:0.8:3: 0.8:1: 0.8:0.6:1: 3;
the mass ratio of the asiatic centella root extract to the giant knotweed rhizome extract to the baical skullcap root extract to the tea leaf extract to the glabrous root extract to the chamomile flower extract to the rosemary leaf extract is 1:3:0.8:0.8:6:0.8: 2;
the mass ratio of taurine, glutathione, tranexamic acid, potassium methoxysalicylate, hydroxyethyl piperazine ethane sulfonic acid and azelaic diamide MEA is 1:7:0.8:2:2: 2.
Example 4
Example 4 differences from example 1:
valine, leucine, isoleucine, threonine, methionine, lysine, tryptophan, glycine, alanine, arginine, cystine, proline, serine, tyrosine, aspartic acid, histidine, glycerol, sodium lactate, potassium hydroxide, citric acid, monosodium citrate, and pyrrolidone carboxylic acid in a mass ratio of 1:0.4: 1.0:0.5:3:1:0.8:0.8:0.8:0.6:2:0.3:2:1:0.5:2:1:0.8:1:1: 3.
The mass ratio of the asiatic centella root extract to the giant knotweed rhizome root extract to the baical skullcap root extract to the tea leaf extract to the glabrous root extract to the chamomile flower extract to the rosemary leaf extract is 1:3:0.8:0.8:5:1: 1.
The mass ratio of taurine, glutathione, tranexamic acid, potassium methoxysalicylate, hydroxyethyl piperazine ethane sulfonic acid and azelaic diamide MEA is 1:6:0.5:2:1: 2.
Example 5
Example 5 differences from example 1:
valine, leucine, isoleucine, threonine, methionine, lysine, tryptophan, glycine, alanine, arginine, cystine, proline, serine, tyrosine, aspartic acid, histidine, glycerol, sodium lactate, potassium hydroxide, citric acid, monosodium citrate, and pyrrolidone carboxylic acid in a mass ratio of 1:0.3: 2.7: 0.3:2:2:0.5:0.5:0.5:1: 0.5:3:2:0.8:3:2:0.5:0.6:0.6: 2.
The mass ratio of the asiatic centella root extract to the giant knotweed rhizome extract to the baical skullcap root extract to the tea leaf extract to the glabrous root extract to the chamomile flower extract to the rosemary leaf extract is 1: 2:0.5:0.5:7:0.6:2.
The mass ratio of taurine, glutathione, tranexamic acid, potassium methoxysalicylate, hydroxyethyl piperazine ethane sulfonic acid and azelaic diamide MEA is 1:7:0.8:3:2: 3.
The preparation method of examples 1 to 4 was:
1) dividing the raw materials into a material A, a material B, a material C, a material D and a material F;
a material: butanediol, propylene glycol with half formula amount, hydrolyzed sclerotium rolfsii gum, xanthan gum, sodium hyaluronate, allantoin and trehalose;
b, material B: p-hydroxyacetophenone and 1, 2-hexanediol;
c, material C: half formula amounts of propylene glycol, valine, leucine, isoleucine, threonine, methionine, lysine, tryptophan, glycine, alanine, arginine, cystine, proline, serine, tyrosine, aspartic acid, histidine, glycerol, sodium lactate, potassium hydroxide, citric acid, monosodium citrate, pyrrolidone carboxylic acid, nicotinamide, centella asiatica root extract, polygonum cuspidatum root extract, scutellaria baicalensis root extract, tea leaf extract, glycyrrhiza glabra root extract, matricaria chamomilla flower extract, and rosemary leaf extract;
d, material: taurine, glutathione, tranexamic acid, potassium methoxysalicylate, hydroxyethyl piperazine ethanesulfonic acid, azelaic diamide MEA and Chinese eaglewood extract;
f, material: fullerene, beta-glucan, ceramide 1, and hexapeptide-1.
2) Heating water to 85 +/-5 ℃, adding the material A, and stirring and dissolving for 15 minutes at 200 rpm;
3) cooling the product obtained in the step 2) to 45 +/-2 ℃, sequentially adding the material B, the material C, the material D and the material F, mixing and stirring for 16 minutes at 200rpm, filtering, inspecting, filling, packaging, inspecting and warehousing.
The preparation method of example 5 is as follows:
1) dividing the raw materials into a material A, a material B, a material C, a material D and a material F;
a material: butanediol, propylene glycol with half formula amount, hydrolyzed sclerotium rolfsii gum, xanthan gum, sodium hyaluronate, allantoin and trehalose;
b, material B: p-hydroxyacetophenone and 1, 2-hexanediol;
c, material C: half formula amounts of propylene glycol, valine, leucine, isoleucine, threonine, methionine, lysine, tryptophan, glycine, alanine, arginine, cystine, proline, serine, tyrosine, aspartic acid, histidine, glycerol, sodium lactate, potassium hydroxide, citric acid, monosodium citrate, pyrrolidone carboxylic acid, nicotinamide, centella asiatica root extract, polygonum cuspidatum root extract, scutellaria baicalensis root extract, tea leaf extract, glycyrrhiza glabra root extract, matricaria chamomilla flower extract, and rosemary leaf extract;
d, material: taurine, glutathione, tranexamic acid, potassium methoxysalicylate, hydroxyethyl piperazine ethanesulfonic acid, azelaic diamide MEA and Chinese eaglewood extract;
f, material: fullerene, beta-glucan, ceramide 1, and hexapeptide-1.
2) Heating water to 85 +/-5 ℃, adding the material A, and stirring at 100rpm for dissolving for 20 minutes;
3) cooling the product obtained in the step 2) to 45 +/-2 ℃, sequentially adding the material B, the material C, the material D and the material F, mixing and stirring for 20 minutes at 100rpm, filtering, inspecting, filling, packaging, inspecting and warehousing.
Example 6
The main differences between example 6 and example 1 are:
the preparation method of the agilawood fullerene essence comprises the following steps:
1) dividing the raw materials into a material A, a material B, a material C, a material D and a material F;
a material: butanediol, propylene glycol with half formula amount, hydrolyzed sclerotium rolfsii gum, xanthan gum, sodium hyaluronate, allantoin and trehalose;
b, material B: p-hydroxyacetophenone and 1, 2-hexanediol;
c, material C: half formula amounts of propylene glycol, valine, leucine, isoleucine, threonine, methionine, lysine, tryptophan, glycine, alanine, arginine, cystine, proline, serine, tyrosine, aspartic acid, histidine, glycerol, sodium lactate, potassium hydroxide, citric acid, monosodium citrate, pyrrolidone carboxylic acid, nicotinamide, centella asiatica root extract, polygonum cuspidatum root extract, scutellaria baicalensis root extract, tea leaf extract, glycyrrhiza glabra root extract, matricaria chamomilla flower extract, and rosemary leaf extract;
d, material: taurine, glutathione, tranexamic acid, potassium methoxysalicylate, hydroxyethyl piperazine ethanesulfonic acid, azelaic diamide MEA and Chinese eaglewood extract;
f, material: fullerene, beta-glucan, ceramide 1, and hexapeptide-1.
2) Mixing the material A uniformly, and stirring at 50rpm at 70 +/-5 ℃ for 20 min;
3) heating water to 85 +/-5 ℃, adding the material C, stirring at 100rpm for dissolving for 20 minutes, and keeping the pH value at 7.6;
4) slowly adding the material obtained in the step 3) into the material obtained in the step 2) at the temperature of 55 +/-5 ℃, uniformly mixing, carrying out high-pressure homogenization for 4 times, wherein the homogenization pressure is 600bar, cooling the material to room temperature, sequentially adding the material B, the material D and the material F, mixing and stirring at 100rpm for 20 minutes, filtering, inspecting, filling, packaging, inspecting and warehousing.
Example 7
The main differences between example 7 and example 1 are:
the preparation method of the agilawood fullerene essence comprises the following steps:
1) dividing the raw materials into a material A, a material B, a material C, a material D and a material F;
a material: butanediol, propylene glycol with half formula amount, hydrolyzed sclerotium rolfsii gum, xanthan gum, sodium hyaluronate, allantoin and trehalose;
b, material B: p-hydroxyacetophenone and 1, 2-hexanediol;
c, material C: half formula amounts of propylene glycol, valine, leucine, isoleucine, threonine, methionine, lysine, tryptophan, glycine, alanine, arginine, cystine, proline, serine, tyrosine, aspartic acid, histidine, glycerol, sodium lactate, potassium hydroxide, citric acid, monosodium citrate, pyrrolidone carboxylic acid, nicotinamide, centella asiatica root extract, polygonum cuspidatum root extract, scutellaria baicalensis root extract, tea leaf extract, glycyrrhiza glabra root extract, matricaria chamomilla flower extract, and rosemary leaf extract;
d, material: taurine, glutathione, tranexamic acid, potassium methoxysalicylate, hydroxyethyl piperazine ethanesulfonic acid, azelaic diamide MEA and Chinese eaglewood extract;
f, material: fullerene, beta-glucan, ceramide 1, and hexapeptide-1.
2) Mixing the material A uniformly, and stirring at 75rpm at 70 +/-5 ℃ for 15 min;
3) heating water to 85 +/-5 ℃, adding the material C, stirring at 200rpm for dissolving for 15 minutes, and keeping the pH value at 7.3;
4) slowly adding the material obtained in the step 3) into the material obtained in the step 2) at the temperature of 55 +/-5 ℃, uniformly mixing, carrying out high-pressure homogenization for 3 times, wherein the homogenization pressure is 800bar, cooling the material to room temperature, sequentially adding the material B, the material D and the material F, mixing and stirring at 200rpm for 16 minutes, filtering, inspecting, filling, packaging, inspecting and warehousing.
Comparative example 1
The main differences between comparative example 1 and example 1 are:
valine, leucine, isoleucine, threonine, methionine, lysine, tryptophan, glycine, alanine, arginine, cystine, proline, serine, tyrosine, aspartic acid, histidine, glycerol, sodium lactate, potassium hydroxide, citric acid, monosodium citrate, and pyrrolidone carboxylic acid in a mass ratio of 1:1:3:2:5:2:1:2:0.3:0.8:0.5:2:3:1:1: 2:2:0.5:0.5:0.6: 1.
The mass ratio of the asiatic centella root extract to the giant knotweed rhizome extract to the baical skullcap root extract to the tea leaf extract to the glabrous root extract to the chamomile flower extract to the rosemary leaf extract is 1:2:1:0.8:3:0.5: 3.
Experimental example 1:
the moisture retention and water supplement capability of the reaction product is measured by measuring the water content of the cuticle of the epidermis in the experiment.
The experimental method comprises the following steps: healthy women aged 35-40 years were selected and subjects received no skin beauty, skin treatment, and other tests that may affect outcome within 1 year. The test environment temperature is 25 +/-2 ℃, the relative humidity is 60 +/-5%, the moisture content of the horny layer of the epidermis at the cheek part is detected by SKICON-200 before the product is used, then the samples of each embodiment and comparative example are recommended to be used in groups, each group of 10 people uses the product for 1 time each day, the moisture content of the horny layer of the epidermis is detected again after the product is continuously used for 1 month, and the change rate of the moisture content of the horny layer of the epidermis is counted. The results are shown in Table 1.
TABLE 1
Before use (us) After use (us) Rate of change (%)
Example 1 229.3±5.23 269.4±5.34 17.49%
Example 2 225.5±6.12 266.5±6.23 18.18%
Example 3 219.1±3.78 280.1±4.23 27.84%
Example 4 230.3±7.12 267.2±5.22 16.02%
Example 5 233.8±4.24 278.8±4.45 19.25%
Example 6 218.9±5.23 258.9±7.34 18.27%
Example 7 226.7±3.67 269.7±5.32 18.97%
Comparative example 1 229.4±5.32 255.3±5.09 11.29%
The result shows that the moisture content of the horny layer of the epidermis of the skin is obviously improved after the essence disclosed by the invention is used, and the formula disclosed by the invention has good moisturizing and hydrating effects.
Experimental example 2:
and (4) determining the content of the amino acid by adopting a high performance liquid chromatography.
A sample to be tested: taking 1mL of sample to be tested, diluting to 20mL with formic acid aqueous solution with pH of 8, performing ultrasonic extraction for 20min, centrifuging at 8000rpm, taking supernatant, filtering with a filter membrane, and taking filtrate for later use.
Blank sample: in each of examples and comparative examples, the sample to which the component to be measured was not added was prepared in the same manner as the test sample.
Illuminating the sample: 50ml of each sample and blank sample of each example are respectively placed in a transparent glass bottle, placed under 8000lx illumination for 8h, and then sampled and prepared according to the method.
Chromatographic conditions are as follows: diamonsil C18 column (200 mm. times.4.6 mm, 5 μm); the flow rate is 0.5 mL/min; the column temperature is 30 ℃; the sample volume is 25 mu L; mobile phase: v (acetonitrile): V (5mmol/L aqueous formic acid) ═ 10: 90; the detection wavelength is 280 nm.
4 batches were produced for each sample tested, and the average was taken 2 times for each batch. The decomposition rate was calculated as peak area and corrected as blank. The results are shown in Table 2. The components to be tested in this experiment were tyrosine and tryptophan.
The decomposition rate (area of peak of sample not illuminated-area of peak of illuminated sample)/area of peak of sample not illuminated.
TABLE 2
Figure BDA0002475291760000131
Note: the different letters in each column represent significant differences (p <0.05)
The results show that:
by inclusion-treating amino acid components such as tyrosine and tryptophan by the preparation methods of example 6 and example 7, the decomposition rate of components such as tyrosine and tryptophan under light conditions is avoided, and the stability of the amino acid components is further improved. The selection of the amounts of the ingredients to be dosed also has an influence on the decomposition rates of tyrosine and tryptophan.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.

Claims (5)

1. The agilawood fullerene essence is characterized by comprising the following raw materials in percentage by mass:
Figure FDA0003103961940000011
Figure FDA0003103961940000021
wherein, the mass ratio of valine, leucine, isoleucine, threonine, methionine, lysine, tryptophan, glycine, alanine, arginine, cystine, proline, serine, tyrosine, aspartic acid, histidine, glycerol, sodium lactate, potassium hydroxide, citric acid, monosodium citrate and pyrrolidone carboxylic acid is 1 (0.3-0.4), (1-2), (0.7-1.0), (0.3-0.5), (2-3), (1-2), (0.5-0.8), (0.6-1), (1-2), (0.3-0.5), (2-3), (1-2), (0.5-0.8), (2-2), (1-2), (0.5-0.8), (0.6-0.6) and (1-0.4);
the mass ratio of the asiatic centella root extract to the giant knotweed rhizome extract to the baical skullcap root extract to the tea leaf extract to the glabrous root extract to the chamomile flower extract to the rosemary leaf extract is 1: (2 to 3), (0.5 to 0.8), (5 to 7), (0.6 to 1), (1 to 2);
the mass ratio of taurine, glutathione, tranexamic acid, potassium methoxysalicylate, hydroxyethyl piperazine ethane sulfonic acid and nonanodiamide MEA is 1 (6-7), (0.5-0.8), (2-3), (1-2) and (2-3);
the preparation method of the agilawood fullerene essence comprises the following steps:
1) dividing the raw materials into a material A, a material B, a material C, a material D and a material F;
a material: butanediol, propylene glycol, hydrolyzed sclerotium rolfsii gum, xanthan gum, sodium hyaluronate, allantoin and trehalose;
b, material B: p-hydroxyacetophenone and 1, 2-hexanediol;
c, material C: propylene glycol, valine, leucine, isoleucine, threonine, methionine, lysine, tryptophan, glycine, alanine, arginine, cystine, proline, serine, tyrosine, aspartic acid, histidine, glycerol, sodium lactate, potassium hydroxide, citric acid, monosodium citrate, pyrrolidone carboxylic acid, nicotinamide, centella asiatica root extract, polygonum cuspidatum root extract, scutellaria baicalensis root extract, tea leaf extract, glycyrrhiza glabra root extract, matricaria chamomilla flower extract, and rosemary leaf extract;
d, material: taurine, glutathione, tranexamic acid, potassium methoxysalicylate, hydroxyethyl piperazine ethanesulfonic acid, azelaic diamide MEA and Chinese eaglewood extract;
f, material: fullerene, beta-glucan, ceramide 1, and hexapeptide-1;
2) uniformly mixing the material A, and stirring at 50-75 rpm for 15-20 min at 70 +/-5 ℃;
3) heating water to 85 +/-5 ℃, adding the material C, stirring and dissolving at 100-200 rpm for 15-20 minutes, and adjusting the pH to 7.3-7.8;
4) slowly adding the material obtained in the step 3) into the material obtained in the step 2) at 55 +/-5 ℃, uniformly mixing, carrying out high-pressure homogenization for 3-4 times at the homogenization pressure of 600-800 bar, cooling the material to room temperature, sequentially adding the material B, the material D and the material F, mixing and stirring at 100-200 rpm for 16-20 minutes, filtering, inspecting, filling, packaging, inspecting and warehousing.
2. The agilawood fullerene essence according to claim 1, which comprises the following raw materials in percentage by mass:
Figure FDA0003103961940000031
Figure FDA0003103961940000041
wherein the mass ratio of valine, leucine, isoleucine, threonine, methionine, lysine, tryptophan, glycine, alanine, arginine, cystine, proline, serine, tyrosine, aspartic acid, histidine, glycerol, sodium lactate, potassium hydroxide, citric acid, monosodium citrate and pyrrolidone carboxylic acid is 1:0.4:2:1.0:0.5:3: 2.6: 0.6:0.8:1:2:0.5:3:2:0.8:3: 0.8:1: 0.8:0.6:1: 3;
the mass ratio of the asiatic centella root extract to the giant knotweed rhizome extract to the baical skullcap root extract to the tea leaf extract to the glabrous root extract to the chamomile flower extract to the rosemary leaf extract is 1:3:0.8:0.8:6:0.8: 2;
the mass ratio of taurine, glutathione, tranexamic acid, potassium methoxysalicylate, hydroxyethyl piperazine ethane sulfonic acid and azelaic diamide MEA is 1:7:0.8:2:2: 2.
3. The agilawood fullerene essence according to claim 1, wherein the pH is 7.6.
4. The agilawood fullerene essence according to claim 1, wherein the homogenization pressure is 600 bar.
5. The agilawood fullerene essence according to claim 1, wherein the mass ratio of the material A to the material C is 1:1.
CN202010361692.8A 2020-04-30 2020-04-30 Agilawood fullerene essence and preparation method thereof Active CN111419755B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010361692.8A CN111419755B (en) 2020-04-30 2020-04-30 Agilawood fullerene essence and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010361692.8A CN111419755B (en) 2020-04-30 2020-04-30 Agilawood fullerene essence and preparation method thereof

Publications (2)

Publication Number Publication Date
CN111419755A CN111419755A (en) 2020-07-17
CN111419755B true CN111419755B (en) 2021-09-21

Family

ID=71552104

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010361692.8A Active CN111419755B (en) 2020-04-30 2020-04-30 Agilawood fullerene essence and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111419755B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112494399A (en) * 2020-12-14 2021-03-16 广州欧正化妆品技术研究院有限公司 Moisturizing skin-brightening repair essence containing saccharomycete rice fermentation product filtrate and preparation method thereof
EP4380541A1 (en) * 2021-09-10 2024-06-12 Colgate-Palmolive Company Personal care compositions based on aminoacids and skin penetration enhancer
CN114028250A (en) * 2021-12-17 2022-02-11 广州市威柯化工有限公司 Whitening composition and application thereof
CN115944551B (en) * 2023-01-19 2024-07-05 麦吉丽生物科技有限公司 Composition and essence with effects of controlling oil, removing acne and removing acne marks and preparation method of composition and essence

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105748360A (en) * 2016-03-25 2016-07-13 无锡简玺生物科技有限公司 Water-locking and moisturizing composition mask and preparation method thereof
CN109453053A (en) * 2018-12-24 2019-03-12 吴华 A kind of agalloch eaglewood peptide skin care compositions and preparation method thereof
CN109464343A (en) * 2018-12-29 2019-03-15 广州灵润生物科技有限公司 A kind of clear essence cream of the polypeptide containing fullerene
CN110339115B (en) * 2019-08-15 2021-11-16 广东芭薇生物科技股份有限公司 Repair essence and preparation method thereof
CN110354043A (en) * 2019-08-20 2019-10-22 广州博今生物科技有限公司 A kind of bright face film of U.S. tender skin of flesh

Also Published As

Publication number Publication date
CN111419755A (en) 2020-07-17

Similar Documents

Publication Publication Date Title
CN111419755B (en) Agilawood fullerene essence and preparation method thereof
CN113616566B (en) Skin care essence for tightening skin and preparation method thereof
CN105147550B (en) A kind of whitening moisturizing face masque liquid containing nostoc sphaeroids kutz extractive and preparation method thereof
TWI774046B (en) Use of solanum muricatum fermented liquid for preparing a composition for promoting skin anti-aging ability, promoting anti-glycation ability, reducing melanin content, increasing skin moisturization, reducing skin texture, reducing skin wrinkles, reducing skin redness and/or reducing fat
CN104758235A (en) Eye-pouch-removing and anti-inflammation eye essence liquid
CN108125892A (en) A kind of marine organism moisture-retention anti-aging cosmetics composition
CN109223677B (en) Coix seed hydrolysate, preparation method thereof and application of coix seed hydrolysate in cosmetics
CN110772444A (en) Skin conditioner and mask for whitening and removing wrinkles and preparation method thereof
CN112675060B (en) Composition and skin care product for resisting skin aging and preparation method thereof
CN110090169A (en) A kind of hyaluronic acid nti-freckle gel
CN110478288A (en) A kind of skin anti-aging composition
CN109810812A (en) A kind of safflower amino acid soap and preparation method thereof
CN110101586A (en) It is a kind of to nourish compact whitening mask patch and preparation method thereof
JP2012232915A (en) Skin care preparation for antiaging
CN108324667A (en) Composition and anti-aging Skin whitening care cosmetics containing light black huge marine algae extract
CN110897958A (en) Anti-aging composition and application thereof
CN105832648A (en) Skin-nourishing anti-aging peony seed oil face mask and manufacturing method thereof
CN115414293A (en) Anti-aging composition and application thereof
CN112807271B (en) Moisturizing composition, essence and preparation method of moisturizing composition
CN115054532A (en) Compound small-molecule active peptide moisturizing secondary polishing essence
CN108836904A (en) A kind of skin care compositions of wrinkle reduction and the preparation method and application thereof
CN107982189A (en) Anti-wrinkle eye cream containing stem cell secretory factors and preparation method thereof
CN108096177A (en) A kind of compound stem cell factor cosmetic composition and its application
TW202216183A (en) Use of peony flower extract for improving skin condition
CN103961288B (en) Essence containing hematite extracting solution and collagen and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20230913

Address after: Room 508, No. 138-2, Xinshi Road, Baiyun District, Guangzhou City, Guangdong Province, 510000

Patentee after: Nanzhi (Guangzhou) Health Technology Co.,Ltd.

Address before: 570100 chuangmeng space, 2nd floor, building B, industry university research building, middle section of Haitao Avenue, Guilin Yang University District, Meilan District, Haikou City, Hainan Province

Patentee before: Haikou nanzhixiang Industry Co.,Ltd.